Accidental overdosage could occur during therapy, particularly in patients with renal impairment. Limited post-marketing experience indicates that adverse events following overdosage are consistent with the adverse event profile described in adverse reactions. Treatment of overdosage should be symptomatic. In normal individuals, rapid renal elimination will occur; in subjects with renal impairment, haemodialysis will remove meropenem and its metabolite.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
